Biofilm formation, icaADBC transcription, and polysaccharide intercellular adhesin synthesis by staphylococci in a device-related infection model.
Biofilm formation of Staphylococcus epidermidis and S. aureus is mediated by the polysaccharide intercellular adhesin (PIA) encoded by the ica operon. We used a device-related animal model to investigate biofilm formation, PIA expression (immunofluorescence), and ica transcription (quantitative transcript analysis) throughout the course of infection by using two prototypic S. aureus strains and one S. epidermidis strain as well as corresponding ica mutants. During infection, the ica mutants were growth attenuated when inoculated in competition with the corresponding wild-type strains but not when grown singly. A typical biofilm was observed at the late course of infection. Only in S. aureus RN6390, not in S. aureus Newman, were PIA and ica-specific transcripts detectable after anaerobic growth in vitro. However, both S. aureus strains were PIA positive in vivo by day 8 of infection. ica transcription preceded PIA expression and biofilm formation in vivo. In S. epidermidis, both PIA and ica expression levels were elevated compared to those in the S. aureus strains in vitro as well as in vivo and were detectable throughout the course of infection. In conclusion, in S. aureus, PIA expression is dependent on the genetic background of the strain as well as on strong inducing conditions, such as those dominating in vivo. In S. epidermidis, PIA expression is elevated and less vulnerable to environmental conditions.
Fluckiger
Ursula
U
Division of Infectious Diseases and Department of Research, University Hospital, Basel, Switzerland.
Ulrich
Martina
M
Steinhuber
Andrea
A
Döring
Gerd
G
Mack
Dietrich
D
Landmann
Regine
R
Goerke
Christiane
C
Wolz
Christiane
C
D018829:Adhesins, Bacterial / Q000235:genetics / Q000378:metabolism; D000581:Amidohydrolases / Q000235:genetics / Q000378:metabolism; D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism*; D018441:Biofilms / Q000254:growth & development*; D004195:Disease Models, Animal; D006168:Guinea Pigs; D006801:Humans; D051379:Mice; D009876:Operon; D011135:Polysaccharides, Bacterial / Q000235:genetics / Q000378:metabolism*; D016459:Prosthesis-Related Infections / Q000382:microbiology* / Q000503:physiopathology; D013203:Staphylococcal Infections / Q000382:microbiology* / Q000503:physiopathology; D013211:Staphylococcus aureus / Q000254:growth & development / Q000472:pathogenicity*; D013212:Staphylococcus epidermidis / Q000254:growth & development / Q000472:pathogenicity*; D014158:Transcription, Genetic
D018829:Adhesins, Bacterial; D001426:Bacterial Proteins; D011135:Polysaccharides, Bacterial; C113579:polysaccharide intercellular adhesin; D000581:Amidohydrolases; C497363:poly-N-acetylglucosamine deacetylase
J Clin Microbiol. 2000 Feb;38(2):877-80
10655405
J Infect Dis. 2003 Sep 1;188(5):706-18
12934187
Infect Immun. 2000 Jul;68(7):3799-807
10858187
J Infect Dis. 2000 Jul;182(1):351-5
10882623
J Bacteriol. 2000 Dec;182(23):6824-6
11073930
J Infect Dis. 2001 Apr 1;183(7):1038-42
11237828
Clin Diagn Lab Immunol. 2001 Mar;8(2):279-82
11238208
J Bacteriol. 2001 Apr;183(8):2624-33
11274123
Infect Immun. 2001 Jun;69(6):4079-85
11349079
J Clin Microbiol. 2001 Jun;39(6):2151-6
11376050
J Clin Microbiol. 2002 Apr;40(4):1569-70
11923401
Infect Immun. 2002 Jun;70(6):2758-62
12010960
J Bacteriol. 2002 Aug;184(16):4400-8
12142410
Infect Immun. 2002 Sep;70(9):4987-96
12183545
Emerg Infect Dis. 2002 Sep;8(9):881-90
12194761
Microb Pathog. 2004 May;36(5):237-45
15043859
Infect Immun. 1982 Jul;37(1):318-26
6179880
J Infect Dis. 1982 Oct;146(4):487-97
7119479
J Clin Microbiol. 1983 Aug;18(2):258-69
6311870
J Clin Microbiol. 1985 Dec;22(6):996-1006
3905855
J Bacteriol. 1988 Sep;170(9):4365-72
2457579
Methods Enzymol. 1991;204:587-636
1658572
Infect Immun. 1992 May;60(5):2048-57
1314224
Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6462-6
1321441
J Infect Dis. 1993 Nov;168(5):1211-8
8228355
APMIS. 1993 Dec;101(12):926-32
8110449
Infect Immun. 1994 Aug;62(8):3244-53
8039894
J Bacteriol. 1996 Jan;178(1):175-83
8550413
J Lab Clin Med. 1996 Jan;127(1):71-80
8592099
J Bone Joint Surg Am. 1996 Apr;78(4):512-23
8609130
Infect Immun. 1996 Aug;64(8):3142-7
8757845
Mol Microbiol. 1996 Jun;20(5):1083-91
8809760
Infect Immun. 1997 Mar;65(3):890-6
9038293
Mol Microbiol. 1997 Jun;24(5):1013-24
9220008
Infect Immun. 1998 Jun;66(6):2871-8
9596762
J Biol Chem. 1998 Jul 17;273(29):18586-93
9660830
Infect Immun. 1999 Feb;67(2):1004-8
9916125
Trends Microbiol. 1998 Dec;6(12):484-8
10036727
Infect Immun. 1999 May;67(5):2627-32
10225932
Infect Immun. 1999 May;67(5):2656-9
10225938
Science. 1999 May 28;284(5419):1523-7
10348739
Infect Immun. 1999 Oct;67(10):5427-33
10496925
J Gen Microbiol. 1952 Feb;6(1-2):95-107
14927856
Med Microbiol Immunol. 2001 Apr;189(3):127-31
11388609
Mol Microbiol. 2001 Jun;40(6):1439-47
11442841
Clin Infect Dis. 2001 Oct 15;33(8):1387-92
11565080
J Clin Microbiol. 2001 Dec;39(12):4595-6
11797608
J Clin Microbiol. 2002 Feb;40(2):382-8
11825946
Med Microbiol Immunol. 2002 Oct;191(2):101-6
12410349
FEMS Immunol Med Microbiol. 2003 Mar 20;35(2):135-40
12628549
Infection. 2003 Mar;31(2):99-108
12682815
J Bacteriol. 2003 May;185(9):2879-86
12700267
Mol Microbiol. 2003 May;48(4):889-99
12753184
Mol Microbiol. 2003 May;48(4):1075-87
12753197
J Infect Dis. 2003 Aug 1;188(3):414-23
12870123
Infect Immun. 2003 Aug;71(8):4595-607
12874339
Infect Immun. 2000 Mar;68(3):1304-11
10678942